Healthcare Facility Procurement Red Line Under Moroccan Law 84-12

1. Key takeaways

Item 17 of Article 1 of Law No. 84-12 defines the “exploitant” as the natural or legal person responsible for a public or private healthcare institution in which one or more devices are operated, and provides that from the date of publication of the law in the Official Gazette, such a person may not purchase any device that is not registered under Article 12 and its implementing texts. Paragraph 2 of Article 43 attaches penalties to the heads of healthcare institutions that violate this rule: Class I and Class IIA devices face fines of MAD 200,000 to 500,000, and Class IIB and Class III devices face 2% to 5% of turnover (floor of MAD 500,000). The practical effect is a procurement red line drawn on the buyer’s side of the market: hospitals and clinics share responsibility for registration status, which turns a supplier’s registration certificate into a hard commercial qualification rather than a formality. The clause also reallocates compliance incentives across the market: buyers now have a legal reason to demand registration evidence, and suppliers have a legal reason to make that evidence impossible to overlook.

2. Legal basis

3. Expert insights

Insight 1: the binding date is the date of publication of the law in the Official Gazette, not the entry into force of the implementing regulations. Item 17 of Article 1 took effect for healthcare institutions on September 19, 2013 — the day Law 84-12 was published in the Official Gazette — whereas the overall entry into force under Article 50 had to wait for the implementing regulations. The procurement-side constraint therefore preceded the full sales-side regime by design: the legislator deliberately made this an early-effect provision. For any assessment of historical purchases, this means the relevant legal test is tied to a specific, easily established date — September 19, 2013 — rather than to the later entry into force of the implementing framework.

Insight 2: the scope of the transition period must accordingly be read with care. Paragraph 2 of Article 50 keeps the “device registration procedures in force on the date of publication of the law” applicable during the transition, while the wording of Article 43 paragraph 2 distinguishes between purchasing unregistered devices “from the date of publication of the law in the Official Gazette (applicable during the transition under Article 50)” and the application of Article 12 “after publication of the implementing texts”. Each period has its own applicable standard, and the two cannot be lumped together. A device lawfully purchased under the transitional standard may still require fresh attention once Article 12 and its implementing texts apply in full, which is an argument for hospitals to re-verify the registration status of their installed base rather than relying on historical procurement files.

Insight 3: the penalty targets the person in charge of the institution personally. The provision refers to “the natural or legal person responsible for a public or private healthcare institution who has purchased one or more unregistered devices”. Responsibility therefore attaches not only to the institution as such but to the individual or entity behind the purchasing decision, which raises the personal risk level of procurement choices. In tenders and purchasing committees, this argues for a documented verification step — recording the certificate number checked and by whom — so that the institution can show diligence in the event of a later question.

Insight 4: this creates a natural compliance selling point for suppliers. A procurement red line on the buyer side means that suppliers able to present a valid registration certificate hold a substantive advantage in tenders. Manufacturers, including those from the Chinese mainland, should treat the registration certificate number as a standard field in tender documents rather than an attachment produced on request. The same logic applies to after-sales communication: every invoice, delivery note and service report is an opportunity to keep the registration status visible to the buyer’s compliance function.

Insight 5: the obligation stacks with the maintenance-continuity duty of Article 10. The same exploitant must also ensure the continuity of device maintenance under the third paragraph of Article 10, for which paragraph 2 item 2 of Article 43 sets a separate penalty. When hospitals evaluate a purchase, they therefore need to look at both the registration status and the maintenance plan — and suppliers should be ready to evidence both. The two obligations also interact operationally: an unregistered device cannot lawfully be purchased, and a registered device without a maintenance arrangement degrades the exploitant’s compliance position over time.

4. Practical recommendations

1. State the registration certificate number in every tender document. Present the certificate number and validity period consistently in quotations, technical bids and contract annexes.
2. Make verification easy for customers. Prepare a one-page registration status sheet — number, holder, class, validity — for the customer’s procurement department to keep on file.
3. Confirm coverage of the tendered models before bidding. Check the certificate’s coverage model by model; never cover a tender item with the certificate of another model in the same series.
4. Provide the maintenance plan together with the tender. Offer a maintenance contract proposal under the third paragraph of Article 10 to answer the buyer’s continuity concerns.
5. Inform customers of their own procurement duty. Explain in commercial discussions how item 17 of Article 1 binds them, turning compliance into a reason to cooperate.

5. Verification checklist

• □ All tendered models have been confirmed as covered by valid registration certificates
• □ Tender documents systematically state the registration certificate number and validity period
• □ A one-page registration status sheet is ready to hand to customers
• □ The maintenance plan is provided in parallel under the third paragraph of Article 10
• □ Customers have been informed of the procurement constraint in item 17 of Article 1
• □ The applicable standards under the Article 50 transition and Article 12 have been checked for both periods
• □ The two-way impact of Article 43 paragraph 2 on buyers and suppliers has been assessed

Regulatory information verified as of October 30, 2026

Post-market support from GRZAN. GRZAN provides post-market compliance support for medical device manufacturers and importers serving the Moroccan market, covering registration status documentation for tenders, vigilance and recall obligations, and responses to inspections and enforcement actions. If you need your tender and procurement compliance package aligned with Law 84-12, contact info@grzanglobal.com.